Published in J Am Soc Nephrol on February 21, 2013
Identification of a major epitope recognized by PLA2R autoantibodies in primary membranous nephropathy. J Am Soc Nephrol (2014) 1.26
Glomerular diseases: membranous nephropathy--a modern view. Clin J Am Soc Nephrol (2013) 1.17
Membranous nephropathy: from models to man. J Clin Invest (2014) 1.05
Identification of the immunodominant epitope region in phospholipase A2 receptor-mediating autoantibody binding in idiopathic membranous nephropathy. J Am Soc Nephrol (2014) 1.03
HLA-DQA1 and PLA2R1 polymorphisms and risk of idiopathic membranous nephropathy. Clin J Am Soc Nephrol (2013) 0.95
Immunopathogenesis of membranous nephropathy: an update. Semin Immunopathol (2014) 0.94
PLA2R-associated membranous glomerulopathy is modulated by common variants in PLA2R1 and HLA-DQA1 genes. Genes Immun (2014) 0.91
The role of complement in membranous nephropathy. Semin Nephrol (2013) 0.90
Genetic variants in membranous nephropathy: perhaps a perfect storm rather than a straightforward conformeropathy? J Am Soc Nephrol (2013) 0.90
Epitope Spreading of Autoantibody Response to PLA2R Associates with Poor Prognosis in Membranous Nephropathy. J Am Soc Nephrol (2015) 0.88
Membranous nephropathy: not just a disease for adults. Pediatr Nephrol (2013) 0.84
Inhibition of nicotinic acetylcholine receptors, a novel facet in the pleiotropic activities of snake venom phospholipases A2. PLoS One (2014) 0.82
Membranous Nephropathy: A Journey From Bench to Bedside. Am J Kidney Dis (2016) 0.81
Insights into kidney diseases from genome-wide association studies. Nat Rev Nephrol (2016) 0.79
Rare Variants in the Complement Factor H-Related Protein 5 Gene Contribute to Genetic Susceptibility to IgA Nephropathy. J Am Soc Nephrol (2016) 0.78
The dominant humoral epitope in phospholipase A2 receptor-1: presentation matters when serving up a slice of π. J Am Soc Nephrol (2014) 0.78
Antiphospholipase A2 Receptor Autoantibodies: A Step Forward in the Management of Primary Membranous Nephropathy. Biomed Res Int (2015) 0.77
TRPC6 single nucleotide polymorphisms and progression of idiopathic membranous nephropathy. PLoS One (2014) 0.77
High-density Association Mapping and Interaction Analysis of PLA2R1 and HLA Regions with Idiopathic Membranous Nephropathy in Japanese. Sci Rep (2016) 0.75
Actualizing the Benefits of Genomic Discovery in Pediatric Nephrology. J Pediatr Genet (2015) 0.75
Can genetics risk-stratify patients with membranous nephropathy? J Am Soc Nephrol (2013) 0.75
Anti-phospholipase A2 Receptor Antibody and Immunosuppression in Membranous Nephropathy: More Evidence for Pathogenicity of Anti-phospholipase A2 Receptor Autoantibodies. J Am Soc Nephrol (2015) 0.75
PLA2R and THSD7A: Disparate Paths to the Same Disease? J Am Soc Nephrol (2017) 0.75
Reappraisal of PLA2R1 in membranous nephropathy: immunostaining method influence and association with IgG4-dominant phenotype. Virchows Arch (2015) 0.75
PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet (2007) 209.92
The human genome browser at UCSC. Genome Res (2002) 168.23
Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol (2000) 128.08
A map of human genome variation from population-scale sequencing. Nature (2010) 121.13
A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res (1988) 77.80
Complement factor H polymorphism in age-related macular degeneration. Science (2005) 31.10
M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med (2009) 11.81
Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. N Engl J Med (2011) 6.34
Structural basis of lectin-carbohydrate recognition. Annu Rev Biochem (1996) 4.29
The C-type lectin-like domain superfamily. FEBS J (2005) 4.22
Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis. N Engl J Med (2010) 3.78
The C-type lectin superfamily in the immune system. Immunol Rev (1998) 3.63
Anti-phospholipase A₂ receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol (2011) 3.23
Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med (2002) 3.15
Role of truncating mutations in MME gene in fetomaternal alloimmunisation and antenatal glomerulopathies. Lancet (2004) 2.82
PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. N Engl J Med (2011) 2.64
Cloning and expression of a membrane receptor for secretory phospholipases A2. J Biol Chem (1994) 1.72
Pathogenesis of membranous nephropathy: recent advances and future challenges. Nat Rev Nephrol (2012) 1.57
Anti-PLA₂R antibodies in membranous nephropathy: ready for routine clinical practice? Neth J Med (2012) 1.42
Single nucleotide polymorphisms in the phospholipase A2 receptor gene are associated with genetic susceptibility to idiopathic membranous nephropathy. Nephron Clin Pract (2010) 1.23
Association of phospholipase A2 receptor 1 polymorphisms with idiopathic membranous nephropathy in Chinese patients in Taiwan. J Biomed Sci (2010) 1.14
The C-type carbohydrate recognition domain (CRD) superfamily. Biochem Soc Trans (1994) 1.07
The plasminogen binding site of the C-type lectin tetranectin is located in the carbohydrate recognition domain, and binding is sensitive to both calcium and lysine. J Biol Chem (1998) 0.93
Genes that link nephritis to autoantibodies and innate immunity. N Engl J Med (2011) 0.86
NT5E mutations and arterial calcifications. N Engl J Med (2011) 8.71
Age and association of kidney measures with mortality and end-stage renal disease. JAMA (2012) 7.20
Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial. Lancet (2013) 7.03
A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol (2002) 6.48
Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. N Engl J Med (2011) 6.34
High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis. N Engl J Med (2007) 5.84
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. Am J Hematol (2005) 5.64
Epilepsy, ataxia, sensorineural deafness, tubulopathy, and KCNJ10 mutations. N Engl J Med (2009) 4.96
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis. Lancet (2012) 4.75
Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities. Nature (2012) 4.26
Epidemiology of contrast material-induced nephropathy in the era of hydration. Radiology (2012) 3.52
Large-scale proteomics and phosphoproteomics of urinary exosomes. J Am Soc Nephrol (2008) 3.22
A road map for efficient and reliable human genome epidemiology. Nat Genet (2006) 3.21
Early-childhood membranous nephropathy due to cationic bovine serum albumin. N Engl J Med (2011) 3.17
Insulin signaling to the glomerular podocyte is critical for normal kidney function. Cell Metab (2010) 3.05
Research capacity. Enabling the genomic revolution in Africa. Science (2014) 3.05
Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA (2009) 2.85
Long-term outcome of biopsy-proven, frequently relapsing minimal-change nephrotic syndrome in children. Clin J Am Soc Nephrol (2009) 2.84
Role of truncating mutations in MME gene in fetomaternal alloimmunisation and antenatal glomerulopathies. Lancet (2004) 2.82
PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. N Engl J Med (2011) 2.64
Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases. Pediatr Nephrol (2008) 2.64
Renal replacement therapy for diabetic end-stage renal disease: data from 10 registries in Europe (1991-2000). Kidney Int (2005) 2.44
Biosimilars and biopharmaceuticals: what the nephrologists need to know--a position paper by the ERA-EDTA Council. Nephrol Dial Transplant (2008) 2.42
Fanconi syndrome and renal failure induced by tenofovir: a first case report. Am J Kidney Dis (2002) 2.41
Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome. Blood (2009) 2.33
Mutations in TRPV4 cause Charcot-Marie-Tooth disease type 2C. Nat Genet (2009) 2.32
Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy. J Am Soc Nephrol (2012) 2.21
Estimating glomerular filtration rate: Cockcroft-Gault and Modification of Diet in Renal Disease formulas compared to renal inulin clearance. Clin J Am Soc Nephrol (2009) 2.12
Proximal tubular cells contain a phenotypically distinct, scattered cell population involved in tubular regeneration. J Pathol (2013) 2.12
COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps. N Engl J Med (2007) 2.02
Steroid-resistant nephrotic syndrome: impact of genetic testing. Ann Saudi Med (2014) 2.02
Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes. Am J Physiol Renal Physiol (2003) 2.00
Gray platelet syndrome: natural history of a large patient cohort and locus assignment to chromosome 3p. Blood (2010) 2.00
Extending prednisolone treatment does not reduce relapses in childhood nephrotic syndrome. J Am Soc Nephrol (2013) 1.90
Mutations in the autoregulatory domain of β-tubulin 4a cause hereditary dystonia. Ann Neurol (2013) 1.90
Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer Res (2003) 1.88
Tracing the origin of glomerular extracapillary lesions from parietal epithelial cells. J Am Soc Nephrol (2009) 1.85
Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy. Kidney Int (2013) 1.84
A clinical score to predict 6-month prognosis in elderly patients starting dialysis for end-stage renal disease. Nephrol Dial Transplant (2008) 1.82
Nephropathic cystinosis in adults: natural history and effects of oral cysteamine therapy. Ann Intern Med (2007) 1.81
Human podocytes adhere to the KRGDS motif of the alpha3alpha4alpha5 collagen IV network. J Am Soc Nephrol (2008) 1.81
Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis. J Am Soc Nephrol (2011) 1.80
Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy. Nephrol Dial Transplant (2012) 1.80
Serum hepcidin: reference ranges and biochemical correlates in the general population. Blood (2011) 1.79
Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening. J Am Soc Nephrol (2006) 1.78
Bartter syndromes and other salt-losing tubulopathies. Nephron Physiol (2006) 1.78
Mutation analysis of 18 nephronophthisis associated ciliopathy disease genes using a DNA pooling and next generation sequencing strategy. J Med Genet (2010) 1.76
Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new (MDRD) prediction equation. Nephrol Dial Transplant (2002) 1.74
ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption. J Clin Invest (2013) 1.74
The renal epidemiology and information network (REIN): a new registry for end-stage renal disease in France. Nephrol Dial Transplant (2005) 1.72
The enzyme 4-hydroxy-2-oxoglutarate aldolase is deficient in primary hyperoxaluria type 3. Nephrol Dial Transplant (2012) 1.71
Glomerular endothelial glycocalyx constitutes a barrier to protein permeability. J Am Soc Nephrol (2007) 1.69
Recurrent membranous nephropathy in an allograft caused by IgG3κ targeting the PLA2 receptor. J Am Soc Nephrol (2012) 1.69
Saturated fatty acids induce insulin resistance in human podocytes: implications for diabetic nephropathy. Nephrol Dial Transplant (2009) 1.68
Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy. Clin Chim Acta (2013) 1.68
Immunochemical and mass-spectrometry-based serum hepcidin assays for iron metabolism disorders. Clin Chem (2010) 1.68
Mutations in the human laminin beta2 (LAMB2) gene and the associated phenotypic spectrum. Hum Mutat (2010) 1.67
A humanized mouse model of idiopathic nephrotic syndrome suggests a pathogenic role for immature cells. J Am Soc Nephrol (2007) 1.66
Prognostic value of risk score and urinary markers in idiopathic membranous nephropathy. Clin J Am Soc Nephrol (2012) 1.64
KCNJ10 gene mutations causing EAST syndrome (epilepsy, ataxia, sensorineural deafness, and tubulopathy) disrupt channel function. Proc Natl Acad Sci U S A (2010) 1.64
Interferon-beta reduces proteinuria in experimental glomerulonephritis. J Am Soc Nephrol (2007) 1.63
Age and comorbidity may explain the paradoxical association of an early dialysis start with poor survival. Kidney Int (2010) 1.63
The emergence of networks in human genome epidemiology: challenges and opportunities. Epidemiology (2007) 1.61
Neurological features of epilepsy, ataxia, sensorineural deafness, tubulopathy syndrome. Dev Med Child Neurol (2013) 1.61
Pathophysiological lessons from rare associations of immunological disorders. Pediatr Nephrol (2008) 1.60
Angiopoietin 1 and vascular endothelial growth factor modulate human glomerular endothelial cell barrier properties. J Am Soc Nephrol (2004) 1.59
Pathogenesis of membranous nephropathy: recent advances and future challenges. Nat Rev Nephrol (2012) 1.57
Association of variants at UMOD with chronic kidney disease and kidney stones-role of age and comorbid diseases. PLoS Genet (2010) 1.57
Idiopathic membranous nephropathy: outline and rationale of a treatment strategy. Am J Kidney Dis (2005) 1.56
Nephrin is critical for the action of insulin on human glomerular podocytes. Diabetes (2007) 1.55
Serum-soluble urokinase receptor concentration in primary FSGS. Kidney Int (2012) 1.55
Mistargeting of peroxisomal EHHADH and inherited renal Fanconi's syndrome. N Engl J Med (2014) 1.53
INF2 mutations in Charcot-Marie-Tooth disease with glomerulopathy. N Engl J Med (2011) 1.53
Comparison of three methods for isolation of urinary microvesicles to identify biomarkers of nephrotic syndrome. Kidney Int (2010) 1.52
The human glomerular podocyte is a novel target for insulin action. Diabetes (2005) 1.49
Lithium-induced nephropathy: Rate of progression and prognostic factors. Kidney Int (2003) 1.48
Validation of the kidney failure risk equation in European CKD patients. Nephrol Dial Transplant (2013) 1.48
Cellular defects in Chediak-Higashi syndrome correlate with the molecular genotype and clinical phenotype. J Invest Dermatol (2007) 1.47